Covalis Capital’s Exelon EXC Stock Holding History

Covalis Capital’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-405,837	Closed	-$15.3M	–	66
2024 Q4	$15.3M	Buy	+405,837	New	+$15.7M	2.23%	16
2022 Q2	–	Sell	-394,580	Closed	-$18.8M	–	69
2022 Q1	$18.8M	Sell	394,580 -158,621	-29%	-$6.72M	5.12%	3
2021 Q4	$22.8M	Buy	+553,201	New	+$20.8M	8.32%	3
2021 Q2	–	Sell	-290,937	Closed	-$9.08M	–	136
2021 Q1	$9.08M	Buy	+290,937	New	+$8.74M	1.86%	17
2020 Q1	–	Sell	-2,757,827	Closed	-$89.7M	–	18
2019 Q4	$89.7M	Buy	2,757,827 +2,575,567	+1,413%	+$83.4M	35.53%	1
2019 Q3	$6.28M	Buy	+182,260	New	+$6.12M	7.01%	4
2018 Q3	–	Sell	-105,150	Closed	-$3.19M	–	29
2018 Q2	$3.19M	Buy	+105,150	New	+$3.01M	1.66%	17
2018 Q1	–	Sell	-432,073	Closed	-$12.1M	–	32
2017 Q4	$12.1M	Buy	+432,073	New	+$12.4M	7.64%	3

Other funds holding EXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Covalis Capital's EXC Position: Q1 2025 in Review

Covalis Capital sold out of Exelon (EXC) in Q1 2025, closing a stake of 405,837 shares — an estimated $15.3M sold.

Covalis Capital first reported a position in EXC in Q4 2017 and held it in 8 quarters. The position peaked at $89.7M in Q4 2019. 1,195 funds tracked by Wall St. Rank hold EXC as of Q1 2025.

Covalis Capital reported no remaining Exelon position as of Q1 2025 after selling out during the quarter.
Covalis Capital sold 405,837 Exelon shares in Q1 2025, an estimated $15.3M.
Covalis Capital first reported a position in Exelon in Q4 2017 and held it in 8 quarters.
Covalis Capital's Exelon position peaked at $89.7M in Q4 2019.
1,195 funds tracked by Wall St. Rank held Exelon as of Q1 2025.

Based on Covalis Capital's 13F filing for Q1 2025, filed 15 May 2025.